Monitoring of clopidogrel treatment by multiple electrode platelet aggregometry;Überwachung der clopidogrel-therapie mit hilfe der mehrfach-elektroden plättchen-aggregometrie

LaboratoriumsMedizin

Volumn 34, Issue 2, 2010, Pages 99-107

  Behr, Tobias ^a   Behr, Werner ^a   Von Scheidt, Wolfgang ^a  

^a KLINIKUM AUGSBURG   (Germany)

Author keywords

Clopidogrel; Impedance aggregometry; Multiplate ; Multiple electrode platelet aggregometry (MEA); Platelet aggregation; Therapy monitoring

Indexed keywords

CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; THROMBIN RECEPTOR ACTIVATING PEPTIDE;

ANEMIA; ARTICLE; BLOOD SAMPLING; BLOOD STORAGE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; HEMATOCRIT; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTIPLE ELECTRODE PLATELET AGGREGOMETRY; PERCUTANEOUS CORONARY INTERVENTION; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

EID: 77951586079     PISSN: 03423026     EISSN: 14390477     Source Type: Journal    
DOI: 10.1515/JLM.2010.014     Document Type: Article

References (26)

1. Ruß M, Cremer J, Krian A, Meinertz T, Werdan K, Zerkowski HR. Differenzialtherapie der chronischen koronaren Herzkrankheit. Dtsch Arztebl Int 2009; 106: 253-261
2. Bonzel T, Erbel R, Hamm. CW, Levenson B, Neumann FJ, Rupprecht HJ, et al. Leitlinie Perkutane Koronarinterventionen (PCI). Clin Res Cardiol 2008; 97: 513-547
3. 3. Wenaweser P, Rey C, Eberli FR, Togni M, Tüller D, Locher S, et al. Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome. Eur Heart J 2005; 26: 1180-1187 (Pubitemid 40863124)
4. 4. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Monger C, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 2007; 369: 667-678 (Pubitemid 46281313)
5. 5. Buonamici P, Marcucci R, Migliorini A, Gensini GF, Santini A, Paniccia R, et al. Impact of platelet reactivity after Clopidogrel administration on drug-eluting stent thrombosis. J Am Coll Cardiol 2007; 49: 2312-2317 (Pubitemid 46891710)
6. Bom GV. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-929
7. 7. Budde U. Diagnose von Funktionsstörungen der Thrombozyten mit Hilfe der Aggregometrie. J Lab Med 2002; 26: 564-571 (Pubitemid 36033748)
8. 8. Geiger J, Teichmann. L, Grossmann R, Aktas B, Steigerwald U, Walter U, et al. Monitoring of Clopidogrel action: comparison of methods. Clin Chem 2005; 51: 957-965 (Pubitemid 40740875)
9. 9. Calatzis A. Vollblutverfahren zur Erfassung der primären Hämostase. J Lab Med 2007; 31: 239-247 (Pubitemid 350224274)
10. 10. Toth O, Calatzis A, Penz S, Losonczy H, Siess W Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thromb Haemost 2006; 96: 781-788 (Pubitemid 44883819)
11. Cardinal DC, Flower RJ. The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods 1980; 3: 135-158
12. Sibbing D, Braun S, Jawanski S, Schomig A, Kastrati A, von Beckerath N. Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after Clopidogrel treatment. Thromb Haemost 2008; 99: 121-126
13. Sibbing D, Braun S, Morath T, Mehilli J, Vogt W, Schömig A, et al. Platelet reactivity after Clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. J Am Coll Cardiol. 2009; 53: 849-856
14. 14. Görlinger K, Jambor C, Hanke A, Dirkmann D, Adamzik M, Hartmann M, et al. Perioperative Coagulation Management and Control of Platelet Transfusion by Point-of-Care Platelet Function Analysis. Transfus Med Hemother 2007; 34: 396-411. (Pubitemid 350249146)
15. Jambor C, Weber C, Gerhardt K, Preibisch D, Zwissler B. Point of care measuring of platelet aggregation with the novel impedance aggregometer Multiplate - The optimal preanalytical conditions required. DAK 2007 4.6.8.
16. 16. Seyfert UT, Haubelt H, Vogt A, Hellstern P. Variables influencing Multiplate(TM) whole blood impedance platelet aggregometry and turbidimetric platelet aggregation in healthy individuals. Platelets 2007; 18: 199-206. (Pubitemid 46744118)
17. 12 receptor. Clin Chem 2006; 52: 383-388
18. Klouche M. Diagnostic methods for platelet function analysis. Transfus Med Hemother 2007; 34: 20-32.
19. Johnson A, Dovlatova N, Heptinstall S. Multiple electrode aggregometry and. P2Y(12) antagonists. Thromb Haemost 2008; 99: 1127-1129
20. Schuhmann CG, Sohn HY, Schiele T, Leibig M, Lison S, Klauss V, et al. Erhöhte individuelle Thrombozytenreagibilität ist ein Risikofaktor für das Vorliegen einer verminderten Clopidogrel-Response im Multiplate Assay. Clin Res Cardiol 2009; 98(Suppl 1): V1680.
21. Spannagl M, Jambor C. Baseline platelet reactivity as determined by TRAP-6 induced aggregation in whole blood is related to the rate of NON-responsiveness to Clopidogrel. Blood 2008; 112: 5362.
22. Levine P. The effect of thrombocytopenia on the determination of platelet aggregation. J Clin Pathol. 1976; 65: 79-82.
23. Schambeck CM. PFA-100®: Globaltest der primären Hämostase? J Lab Med 2002; 26: 557-562
24. Haque SF, Matsubayashi H, Izumi S, Sugi. T, Arai T, Kondo A, et al. Sex difference in platelet aggregation detected by new aggregometry using light scattering. Endocr J 2001; 48: 33-41.
25. Zuern CS, Lindemann S, Gawaz M. Platelet function and response to aspirin: gender-specific features and implications for female thrombotic risk and management. Semin Thromb Hemost 2009; 35: 295-306.
26. Behr T, Kuch B, Behr W, von Scheidt W Publikation in Vorbereitung.